Bain Capital Specialty Finance, Inc. annual report, FY2022

Bain Capital Specialty Finance, Inc. — 2022 Form 10-K

Reporting period: Fiscal year ended December 31, 2022; filed February 28, 2023. The company is an externally managed business development company (BDC) and regulated investment company (RIC), focused primarily on senior lending to middle-market businesses.

Financial and portfolio highlights

Metric20222021
Total investment income$219.5 million$197.4 million
Net investment income after tax$102.7 million$87.7 million
Net increase in net assets from operations$105.5 million$119.8 million
Net asset value per share at year-end$17.29$17.04
Investment portfolio fair value$2.387 billion$2.289 billion
Debt principal outstanding$1.396 billion$1.431 billion
Asset coverage ratio180%177%
Cash, foreign cash and restricted cash$125.7 million$203.6 million
  • Annual net investment income was about 46.8% of investment income, versus 44.4% in 2021. Net investment income per share rose to $1.59 from $1.36; distributions declared were $1.38 per share, compared with $1.36.
  • Fourth-quarter 2022 investment income was $62.4 million, net investment income after tax was $24.2 million, and net increase in net assets from operations was $43.5 million. For fourth-quarter 2021, the comparable amounts were $51.5 million, $21.9 million, and $22.3 million.
  • Cash flow from operating activities was negative $316.8 million, primarily reflecting investment purchases; financing activities provided $238.3 million. Year-end cash and restricted cash decreased by $77.9 million before the effect of exchange rates.
  • At year-end, the Sumitomo revolving facility had $443 million drawn against $665 million of commitments, leaving approximately $222 million available. A separate $50 million revolving loan from the Advisor had no borrowings. The company reported compliance with Sumitomo facility covenants.
  • Investments were $2.420 billion at amortized cost and $2.387 billion at fair value. First-lien senior secured loans were 68.3% of portfolio fair value, down from 77.5% a year earlier. Approximately 94.5% of debt investments by fair value bore floating rates.
  • The portfolio included five loans to three issuers on non-accrual, valued at $38.4 million, or 1.6% of portfolio fair value. There were no non-accrual loans at year-end 2021. Investments rated 3 or 4 accounted for 9.2% of portfolio fair value; rating 4 represented 1.6%, versus none in 2021.

Material changes and unusual items

  • Investment income increased 11.2%, while net investment income increased 17.1%. Management cited higher dividend and other fee income, including one-time fees, and a higher weighted-average portfolio yield: 11.4% at amortized cost, compared with 7.6% in 2021.
  • Despite higher net investment income, operating results declined from $119.8 million to $105.5 million. Net realized gains were $22.4 million, while net unrealized depreciation was $19.6 million. Investment unrealized depreciation reflected wider credit spreads and negative valuation adjustments.
  • The company prepaid its remaining $112.5 million of 8.50% senior notes due 2023 in September 2022. A $0.7 million realized loss was recorded on extinguishment of debt.
  • The Sumitomo revolving facility was upsized several times to $665 million and transitioned from LIBOR to SOFR-based provisions. The company also sold 70% of its 2018-1 CLO interests to SLP, deconsolidating the CLO notes.
  • Unfunded loan commitments increased to $303.7 million from $234.0 million, representing potential future funding needs subject to contractual conditions.
  • Year-end market price was $11.90 per share versus NAV of $17.29, an approximately 31% discount. The filing notes the stock has historically traded below NAV.

Outlook, risks and oversight

  • The filing does not provide numerical earnings or investment guidance. Management describes continued investment activity as dependent on credit-market conditions, available capital, competition, and portfolio-company needs. It highlights uncertainty from inflation, central-bank rate actions, market volatility, the war in Ukraine, and possible renewed COVID-19 disruption.
  • Rising rates may boost income on the predominantly floating-rate portfolio, but can also strain borrowers’ ability to service debt and refinance. The filing’s sensitivity analysis estimates that a 100-basis-point increase in base rates would increase annual net investment income by approximately $11.4 million, assuming other conditions remain unchanged.
  • Key risks include portfolio defaults and valuation uncertainty, illiquidity, leverage, refinancing and covenant risks, concentration, foreign-currency exposure, and the possibility of restricted distributions. The company’s asset coverage was 180%, above the 150% statutory minimum, but leverage magnifies gains and losses.
  • Fair value depends substantially on estimates: $2.119 billion of investments were Level 3 assets using significant unobservable inputs. The auditor identified Level 3 valuation as a critical audit matter. PricewaterhouseCoopers issued an unqualified opinion on the financial statements and concluded internal control over financial reporting was effective.
  • The company reported no material pending legal proceedings. The filing describes the Advisor’s fee structure and related-party arrangements as potential conflicts of interest; income incentive fees may include accrued PIK or OID income not yet received in cash.

Investor facts to verify

  • Reconcile portfolio performance, rating changes, non-accrual balances, and the $38.4 million year-end fair value of non-accrual investments.
  • Review assumptions and sensitivities underlying Level 3 valuations, especially comparative yields, discount rates, and comparable-company multiples.
  • Check current borrowing, availability, maturity terms, covenant headroom, and asset coverage, including the consequences of the 2023-note repayment and Sumitomo facility usage.
  • Assess the quality and cash realization of income growth, including one-time fees, dividend income, PIK/OID accruals, and the sustainability of distributions.
  • Evaluate the $303.7 million of unfunded commitments alongside available liquidity, and confirm whether portfolio-company conditions have changed since year-end.
  • Compare the market price with NAV and review subsequent portfolio, distribution, and financing disclosures; this filing provides no post-year-end operating guidance.